The Million Hearts initiative launched in 2012 set a lofty goal of preventing 1 million cardiovascular deaths in 5 years, but did not quite achieve that target. According to the program’s executive director, Janet Wright, MD, FACC, Million Hearts will continue to make progress in part due to the solid foundations it has formed in the initial stage.
The Million Hearts initiative launched in 2012 set a lofty goal of preventing 1 million cardiovascular deaths in 5 years, but did not quite achieve that target. According to the program’s executive director, Janet Wright, MD, FACC, Million Hearts will continue to make progress in part due to the solid foundations it has formed in the initial stage.
Transcript (slightly modified)
What are the goals of the Million Hearts initiative?
The aim of Million Hearts 2022 is exactly the aim of Million Hearts 1.0, and that is to prevent a million cardiovascular events over a 5-year time frame. We made progress in our first 5 years, but I don’t think we’re going to get to a million. The projected numbers indicate we’ll probably fall short of that.
But we’ve amassed extraordinary partnerships and instituted policies. We’ve seen programs and pilots be launched during the first 5 years that will extend well beyond and will continue to make improvements in cardiovascular health and cardiovascular care.
What did your team learn from the obstacles the initiative has encountered in the first stage?
What we learned in 5 years of working is that change is hard, and it takes time. We’re frustrated by the slow pace of that change, but we did see progress. Over the 5 years of 2012 to 2016, we saw blood pressure control improve by about 1% per year. In order to deliver a million events, our model showed that we needed improvement at 5% per year.
The good news is that we saw, we met, and we learned from high performers in blood pressure control around the country over that 5 years’ time, so we know that high performance is possible, and many of those lessons turned into success stories that are available on our website.
With cholesterol, we saw an improvement a little bit greater, and we’re going to get close to the population level target that we set, but we’re not going to get all the way there. We did see a target reached in terms of smoking cessation, and it’s due to collective efforts around the country. In fact, 7 million people had stopped smoking over the period of Million Hearts.
We’ve seen a little bit of an improvement in aspirin, but we didn’t make any headway at all in sodium reduction. All of those factors needed to occur together in order to prevent a million.
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen